Valeant Pharmaceuticals International (NYSE:VRX)
CAPS Rating:
A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
RSS Headlines
Fool UK
Recs
undervalued, EPS 5 Year Growth (%) 199.82